LAB International

37 articles about LAB International

• LAB International Announces Positive Results from its Growth Hormone Releasing Hormone (GHRH) Phase II Trial

  7/12/2007

• LAB International Announces Name Change to Akela Pharma Inc.

  7/12/2007

• LAB International Licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica N.V. for Europe

  6/21/2007

• LAB International to Hold its Annual General Meeting of Shareholders June 22, 2007 in Montreal

  6/19/2007

• LAB International Reports Results for First Quarter of Fiscal 2007

  5/15/2007

• LAB International to Hold First Quarter 2007 Conference Call and Webcast

  5/10/2007

• LAB International Reports Results for Fourth Quarter and Fiscal 2006

  3/26/2007

• LAB International to Hold Fourth Quarter and Fiscal 2006 Conference Call and Webcast

  3/21/2007

• LAB International Announces Positive Results from the Open-Label Phase IIb Fentanyl TAIFUN(R) Trial - New Patent Application Submitted

  3/5/2007

• LAB International Completes Patient Enrollment In Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial

  2/8/2007

• LAB International Initiates Patient Enrollment In The Extension Of Its Phase IIb Fentanyl TAIFUN(R) Trial

  1/31/2007

• LAB International Announces The Signing Of The Definitive Purchase And Sale Agreement For The Acquisition Of PharmaForm LLC; Management Team Strengthened

  1/11/2007

• LAB International Reports Results For Third Quarter Of Fiscal 2006

  11/14/2006

• LAB International To Hold Third Quarter 2006 Results Conference Call And Webcast

  11/13/2006

• LAB International Announces Letter Of Intent To Acquire PharmaForm LLC

  10/26/2006

• LAB International Reports Positive Results From Its LAB-CGRP Phase IIA Study

  10/4/2006

• LAB International Completes Patient Enrollment In LAB-CGRP Phase IIa Trial

  8/9/2006

• LAB International To Hold Second Quarter 2006 Results Conference Call And Webcast

  8/8/2006

• LAB International Announces The Closing Of Lab Research Inc. Initial Public Offering

  8/3/2006

• LAB International Initiates Enrollment In Phase IIb Fentanyl TAIFUN(R) Trial

  6/13/2006